ASSAY METHOD DEVELOPMENT AND VALIDATION OF CILNIDIPINE AND RAMIPRIL, CHARACTERIZATION OF ITS DEGRADANTS BY USING LC-MS/MS
DOI:
https://doi.org/10.22159/ijap.2022v14i2.43570Keywords:
Cilnidipine, Ramipril, Development, Validation, RP-HPLCAbstract
Objective: The current study focused on the development, validation of Ramipril and Cilnidipine using HPLC and characterization of forced degradation products using LC-MS/MS.
Methods: Simple, accurate, and precise method has been developed for the simultaneous estimation of Cilnidipine and Ramipril in tablet type of dosage form using X-bridge phenyl column (150x4.6 mm, 3.5m) with mobile phase of buffer and Acetonitrile in the 30:70 v/v ratio was pumped through a column with a 1 ml/min flow rate. The buffer used in this process was 0.1 percent tri ethyl amine in 1 lt of water and adjust its pH-2.5 with 0.1 percent ortho phosphoric acid. At ambient temperature, chromatography was isocratically performed and run time was 8 min. 240 nm was the optimized wave length.
Results: Cilnidipine and Ramipril retention times were 2.79 min, 5.11 min. respectively. By injecting the norm six times, device parameters of suitability have been studied and the results were found to be well under the acceptance criteria. This approach offers strong linearity over a range of 2-30 µg/ml Cilnidipine 1-15 µg/ml Ramipril concentrations. The regression coefficient R2>0.999 from the calibrated curve implies that the linearity of the system was within the range.
Conclusion: The system was validated by using HPLC in terms of accuracy, linearity, method precision, accuracy, limit of detection, limit of quantification, robustness, degradation and the degradation products were characterized by using LC-MS/MS.
Downloads
References
Mohanakumar S, Telinius N, Kelly B, Hjortdal V. Reduced lymphatic function predisposes to calcium channel blocker edema: a randomized placebo-controlled clinical trial. Lymphat Res Biol. 2020;18(2):156-65. doi: 10.1089/lrb.2019.0028. PMID 31429625.
Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386(9995):801-12. doi: 10.1016/S0140-6736(14)61468-9, PMID 25832858.
Katsura M, Shibasaki M, Hayashida S, Torigoe F, Tsujimura A, Ohkuma S. Increase in expression of alpha1 and alpha2/delta1 subunits of L-type high voltage-gated calcium channels after sustained ethanol exposure in cerebral cortical neurons. J Pharmacol Sci. 2006;102(2):221-30. doi: 10.1254/jphs.fp0060781, PMID 17031067.
Justiniano CF, Evans DC, Cook CH, Eiferman DS, Gerlach AT, Beery PR, Lindsey DE, Saum GE, Murphy CV, Miller SF, Papadimos TJ, Steinberg SM, Stawicki SP. Comorbidity–polypharmacy score: a novel adjunct in post-emergency department trauma triage. J Surg Res. 2013;181(1):16-9. doi: 10.1016/j.jss.2012.05.042, PMID 22683074.
Starfield B, Lemke KW, Bernhardt T, Foldes SS, Forrest CB, Weiner JP. Comorbidity: implications for the importance of primary care in ’case’ management. Ann Fam Med. 2003;1(1):8-14. doi: 10.1370/afm.1, PMID 15043174.
Batra AS, Balaji S. Fetal arrhythmias: diagnosis and management. Indian Pacing Electrophysiol J. 2019;19(3):104-9. doi: 10.1016/j.ipej.2019.02.007, PMID 30817991.
Heist EK, Ruskin JN. Drug-induced arrhythmia. Circulation. 2010;122(14):1426-35. doi: 10.1161/CIRCULATIONAHA.109.894725, PMID 20921449.
McMurray JJ, Pfeffer MA. Heart failure. Lancet. 2005;365(9474):1877-89. doi: 10.1016/S0140-6736(05)66621-4, PMID 15924986.
Von Lueder TG, Atar D, Krum H. Diuretic use in heart failure and outcomes. Clin Pharmacol Ther. 2013;94(4):490-8. doi: 10.1038/clpt.2013.140, PMID 23852396.
Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B, EMPA-REG Outcome Investigators. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375(4):323-34. doi: 10.1056/NEJMoa1515920, PMID 27299675.
Jiang S, Wang Y, Zhang Z, Dai P, Yang Y, Li W. Accuracy of hematuria for predicting non-diabetic renal disease in patients with diabetes and kidney disease: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2018;143:288-300. doi: 10.1016/j.diabres.2018.07.027, PMID 30059756.
Kathiresan S, Srivastava D. Genetics of human cardiovascular disease. Cell. 2012;148(6):1242-57. doi: 10.1016/j.cell.2012.03.001, PMID 22424232.
Hooper L, Martin N, Abdelhamid A, Davey Smith G. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database Syst Rev. 2020;5:CD011737. doi: 10.1002/14651858.CD011737. PMID 32428300
Lewis DW, Dorbad D. The utility of neuroimaging in the evaluation of children with migraine or chronic daily headache who have normal neurological examinations. Headache. 2000;40(8):629-32. doi: 10.1046/j.1526-4610.2000.040008629.x, PMID 10971658.
Bronstein AM, Lempert T. Management of the patient with chronic dizziness. Restor Neurol Neurosci. 2010;28(1):83-90. doi: 10.3233/RNN-2010-0530, PMID 20086285.
Muncie HL, Sirmans SM, James E. Dizziness: approach to evaluation and management. Am Fam Physician. 2017;95(3):154-62. PMID 28145669.
Gibson PG, Ryan NM. Cough pharmacotherapy: current and future status. Expert Opin Pharmacother. 2011;12(11):1745-55. doi: 10.1517/14656566.2011.576249, PMID 21524236.
Tapper EB, Lok AS. Use of liver imaging and biopsy in clinical practice. N Engl J Med. 2017;377(8):756-68. doi: 10.1056/NEJMra1610570, PMID 28834467.
Bernstein JA, Cremonesi P, Hoffmann TK, Hollingsworth J. Angioedema in the emergency department: a practical guide to differential diagnosis and management. Int J Emerg Med. 2017;10(1):15. doi: 10.1186/s12245-017-0141-z, PMID 28405953.
Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G. Nonallergic angioedema: role of bradykinin. Allergy. 2007;62(8):842-56. doi: 10.1111/j.1398-9995.2007.01427.x, PMID 17620062.
Kovesdy CP. Updates in hyperkalemia: outcomes and therapeutic strategies. Rev Endocr Metab Disord. 2017;18(1):41-7. doi: 10.1007/s11154-016-9384-x, PMID 27600582.
Evans KJ, Greenberg A. Hyperkalemia: a review. J Intensive Care Med. 2005;20(5):272-90. doi: 10.1177/0885066605278969, PMID 16145218.
Thomas MC. Diuretics, ACE inhibitors and NSAIDs-the triple whammy. Med J Aust. 2000;172(4):184-5. doi: 10.5694/j.1326-5377.2000.tb125548.x, PMID 10772593.
Kumar R, Singh VP, Baker KM. The intracellular renin–angiotensin system: implications in cardiovascular remodeling. Curr Opin Nephrol Hypertens. 2008;17(2):168-73. doi: 10.1097/MNH.0b013e3282f521a8, PMID 18277150.
Swati K, Abhishek P, Sushank S, Bothiraja C, Atmaram P. High-performance liquid chromatography for the simultaneous estimation of cefoperazone and sulbactam in rat plasma and its importance in therapeutic drug monitoring. Int J Pharm Pharm Sci. 2020;12:92-7.
Potturi Ramadevi, Kantipudi Rambabu. Bioanalytical method development and validation for ezetimibe and pitavastain and its applications to pharmacokinetic studies in rabbit plasma by using LCMS/MS. ijrps;11(4):7854-62. doi: 10.26452/ijrps.v11i4.4670.
Eluru A. Surendra babu K. Bio analytical method development and validation for Aplidine in rat plasma and their pharmacokinetic studies by LCMS. World J Pharm Pharm Sci. 2019;8:1201-9.
Ramchandran D, Kethipalli A, Mannam K. Bio analytical method development and validation of daunorubicin and cytrarabine in rat plasma by LC-MS/MS and its application in pharmacokinetic studies. J Pharm Sci Res. 2020;12:381-6.
Vijayakumari M, Reddy Ch B. Stability indicating validated hplc method for the determination of zanubrutinib in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res. 2020;13:159-62.
Shalini K, Ilango K. Development, Evaluation and RP-HPLC method for simultaneous estimation of quercetin, ellagic acid and kaempferol in a polyherbal formulation. Int J Appl Pharm. 2021;13:183-92.
Senthil Rajan D, Muruganathan G, Shivkumar K, Ganesh T. Development and validation of hplc method for simultaneous quantification of vasicine, glycyrrhizin and piperine in poly herbal cough syrup. Int J Curr Pharm Res. 2020;12:15-9.
Malak Y, Al-Bathish AA, Gazy MK El-Jamal. Rp-hplc and chemometric methods for the determination of two anti-diabetic mixtures; metformin hydrochloride-canagliflozin and metformin hydrochloride-gliclazide in their pharmaceutical formulation. Int J Pharm Pharm Sci. 2020;12:83-94.
Girija KS, Kasimala BB, Anna VR. A new high-performance liquid chromatography method for the separation and simultaneous quantification of eptifibatide and its impurities in pharmaceutical injection formulation. Int J App Pharm. 2021;13:165-72. doi: 10.22159/ijap.2021v13i2.39895.
Balaji Gupta VLN. T, Venkateswara Rao B, Kishore babu B. RP-HPLC (stability-indicating) based assay method for the simultaneous estimation of Doravirine, tenofovir disoproxil fumarate and lamivudine. Int J Appl Pharm. 2021;13:153-9.
Malathi S, Arunadevi N. Development and validation of stability-indicating simultaneous estimation of metformin and alogliptin in tablets by high-performance thin-layer chromatography. Int J Pharm Pharm Sci. 2020;12:68-73.
Bhavani P, Prasada Rao K, Mohan S. Novel validated reversed-phase high-performance liquid chromatography method for determination of glucosamine, diacerein, and methyl sulfonyl methane in micro-sample rat plasma and its application to pharmacokinetic and dissolution studies. Asian J Pharm Clin Res. 2020;13:50-63. doi: 10.22159/ajpcr.2020.v13i12.36547.
International conference on harmonization. ICH harmonized tripartite guideline. Validation of analytical procedures: text and methodology. Vol. Q2(R1); 2005.
Naresh Kumar DS, Patel D. Stability indicating chromatographic method development and validation for the simultaneous estimation of escitalopram oxalate and flupentixol in its pharmaceutical dosage form by HPLC. WJPR. 2017;6:549-66.
Manoranjani M. A study of method development, validation and forced degradation for simultaneous quantification of cisplatin and fluorouracil in bulk and pharmaceutical dosage form by RP-HPLC. J Pharm Sci and Res. 2021;13:155-61.
Mayanka Singh M, Manoj Charde M, Rajesh Shukla R, Rita MC. Determination of calcipotriene in calcipotriene cream 0.05% w/w by RP-HPLC method development and validation. Research J Pharm and Technol. 2011;4:1219-23.
Hemanth Kumar AK, Sudha V, Vijayakumar A, Padmapriyadarsini C. Simultaneous method for the estimation of bidaquiline and delamanid in human plasma using high -performance liquid chromatography. Int J Pharm Pharm Sci. 2021;13:36-40.
Shanmugasundaram P, Kamarapu S K. RP-HPLC method for the simultaneous estimation and validation of amlodipine besylate and atenolol in bulk and tablet dosage form in biorelevant dissolution medium (Fassif). Research J Pharm and Technol. 2017;10(10):3379-85. doi: 10.5958/0974-360X.2017.00601.1.
Sruthi A, Uttam Prasad P. Stability indicating method development and validation of fimasartan by reverse phase high-performance liquid chromatography in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res. 2021;14:138-46.
Gadhvi MP, Bhandari A, Suhagia BN, Desai UH. Development and validation of RP-HPLC method for simultaneous estimation of atazanavir and ritonavir in their combined tablet dosage form. Research J Pharm and Technol. 2013;6:200-3.
Narasimha S, Lakka NS, Chandrasekar Kuppan C, Kona S, Srinivas KS, Raviteja Yarra R. Separation and characterization of new forced degradation products of dasatinib in tablet dosage formulation using LC–MS and stability-indicating HPLC methods. Chromatographia. 2020;83(8):947-62. doi: 10.1007/s10337-020-03920-0.
kumar AS, Manidipa Debnath, Seshagiri Rao JVLN, Gowri Sankar D. Development and validation of a sensitive RP-HPLC method for simultaneous estimation of rosuvastatin and fenofibrate in tablet dosage form by using PDA detector in gradient mode. Res J Pharm and Tech 2016;9:549-54.
Chavan BB, Vijaya jyothi P, Kalariya PD, Srinivas R, Talluri MVNK, Pradipbhai D Kalariya, et al. Alcaftadine: selective separation and characterization of degradation products by LC-QTOF-MS/MS. Chromatographia. 2018;81(4):631-8. doi: 10.1007/s10337-018-3489-1.
Published
How to Cite
Issue
Section
Copyright (c) 2022 M. MANORANJANI
This work is licensed under a Creative Commons Attribution 4.0 International License.
